iifl-logo-icon 1

Vilin Bio Med Ltd Share Price

18
(-1.37%)
Jul 18, 2024|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open18.05
  • Day's High18.05
  • 52 Wk High30.45
  • Prev. Close18.25
  • Day's Low18
  • 52 Wk Low15.75
  • Turnover (lac)1.44
  • P/E150
  • Face Value10
  • Book Value16.37
  • EPS0.12
  • Mkt. Cap (Cr.)25.11
  • Div. Yield0
No Records Found

Vilin Bio Med Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

18.05

Prev. Close

18.25

Turnover(Lac.)

1.44

Day's High

18.05

Day's Low

18

52 Week's High

30.45

52 Week's Low

15.75

Book Value

16.37

Face Value

10

Mkt Cap (₹ Cr.)

25.11

P/E

150

EPS

0.12

Divi. Yield

0

Vilin Bio Med Ltd Corporate Action

24 Aug 2023

12:00 AM

AGM

Announcement Date: 24 Aug, 2023

arrow

20 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Vilin Bio Med Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vilin Bio Med Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|02:25 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 64.51%

Foreign: 0.00%

Indian: 64.51%

Non-Promoter- 35.48%

Institutions: 0.00%

Non-Institutions: 35.48%

Custodian: 0.00%

Share Price

Vilin Bio Med Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

9.95

3.3

3.3

3.3

Preference Capital

0

0

0

0

Reserves

0.73

4.1

4.06

3.94

Net Worth

10.68

7.4

7.36

7.24

Minority Interest

View Balance Sheet
Loading...

No Record found

View Profit & Loss
Loading...

No Record found

View Cash Flow
Loading...

No Record found

View Ratios

No Record found

Vilin Bio Med Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,568.65

123.313,76,323.69867.60.865,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,519.8

76.171,19,994.455310.662,259507.93

Cipla Ltd

CIPLA

1,485.5

32.291,19,928.541,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,144.45

33.511,15,173.541,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,636

25.851,10,759.071,034.80.65,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vilin Bio Med Ltd

Management

Register Office

Registrar Office

Independent Director

Veerareddy Vallapureddy

Independent Director

Rakesh Kumar Chandak

Managing Director

S Viswa Prasad

Whole-time Director

Anuj Bajpai

Non Executive Director

S Padmaja Kalyani

Company Sec. & Compli. Officer

Ashdeep Kaur

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vilin Bio Med Limited was originally incorporated as a public limited company dated June 29, 2005, which commenced business on July 11, 2005 issued by Registrar of Companies, Andhra Pradesh, Hyderabad.The Company is engaged in domestic business of manufacturing Pharmaceuticals products and the Manufacturing Unit is located in Roorkee, in the State of Uttarakhand. In order to maintain competitiveness and to further the cause of Healthcare, Company has laid a R&D Foundation and state of the art Manufacturing Facility in Roorkee. The major products for manufacturing dosage forms consist of Oral Liquid (Syrups/Suspensions/Dry Powders (eta & Non eta-Lactam), Tablets & Capsules (eta & Non eta-Lactam) and External Preparations.Ointments along with similar products like Creams, Lotions, Gels or Pates are certain formulations primarily designed to be applied to the skin. Beta-Lactam are a group of medicines that are used to treat infections caused by some germs (bacteria and certain parasites). They do not work against infections that are caused by viruses - for example, the common cold or flu. There are various type of dosages in this group like Tablets, Capsules, Injection and Dry Syrups for Oral Solution. Non-Beta-Lactam Tablets & Capsule Products group medicines are generally used for general diseases like Cold, Flu, Fever, Anti-gastrological, Antimalaria,and several other viral diseases. Antibiotics are normally only prescribed for more serious bacterial infections, as many inf
Read More

Company FAQs

What is the Vilin Bio Med Ltd share price today?

Down Arrow

The Vilin Bio Med Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is Rs.₹18 today.

What is the Market Cap of Vilin Bio Med Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vilin Bio Med Ltd is ₹25.11 Cr. as of 18 Jul ‘24

What is the PE and PB ratio of Vilin Bio Med Ltd?

Down Arrow

The PE and PB ratios of Vilin Bio Med Ltd is 150 and 1.10 as of 18 Jul ‘24

What is the 52 Week High and Low of Vilin Bio Med Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Vilin Bio Med Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vilin Bio Med Ltd is ₹15.75 and ₹30.45 as of 18 Jul ‘24

What is the CAGR of Vilin Bio Med Ltd?

Down Arrow

Vilin Bio Med Ltd's CAGR for 5 Years at N/I%, 3 Years at N/I%, 1 Year at -13.46%, 6 Month at -26.83%, 3 Month at -10.00% and 1 Month at -4.51%.

What is the shareholding pattern of Vilin Bio Med Ltd?

Down Arrow

The shareholding pattern of Vilin Bio Med Ltd is as follows:
Promoters - 64.52 %
Institutions - 0.00 %
Public - 35.48 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.